Characteristic | Patient | |
---|---|---|
 | No | % |
Sex | Â | Â |
   Male | 26 | 56.5 |
   Female | 20 | 43.5 |
Age, years | Â | Â |
   Median | 51 |  |
   Range | 23-68 |  |
ECOG performance status | Â | Â |
   0 | 8 | 17.4 |
   1 | 36 | 78.3 |
   2 | 2 | 4.3 |
Prior Therapy | 46 | Â |
   Chemotherapy (including cytokine and TKI) |  |  |
1 | 21 | Â |
2 | 10 | Â |
≥3 | 15 |  |
   Radiotherapy | 13 |  |
   Surgery | 39 |  |
   Other (Endocrine/Intervention) | 7 |  |
Measurability of baseline disease | Â | Â |
   Measurable | 45 | 97.8 |
   Unmeasurable | 1 | 2.1 |
Primary tumor site | Â | Â |
   Gastrointestinal tract | 34 | 73.9 |
   Bronchus/Lung | 3 | 6.5 |
   Breast | 3 | 6.5 |
   Other | 6 | 13 |